CB Scientific Inc
Cardiac Biotech Solutions Inc., through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally. It offers My-Cardia devices, interactive cloud-based acquisition software, and smartphone apps for patients at risk of abnormal heart rhythms. The company was formerly known as CB Scientific, Inc. and changed its name to Card… Read more
CB Scientific Inc (CBSC) - Total Liabilities
Latest total liabilities as of December 2025: $2.61 Million USD
Based on the latest financial reports, CB Scientific Inc (CBSC) has total liabilities worth $2.61 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CB Scientific Inc - Total Liabilities Trend (2016–2025)
This chart illustrates how CB Scientific Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CB Scientific Inc Competitors by Total Liabilities
The table below lists competitors of CB Scientific Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fidelity China Special Situations PLC
LSE:FCSS
|
UK | GBX51.24 Million |
|
Draw Distance SA
WAR:DDI
|
Poland | zł9.02 Million |
|
Max’s Group Inc
PSE:MAXS
|
Philippines | ₱9.31 Billion |
|
Seafront Resources Corp
PSE:SPM
|
Philippines | ₱61.70 Million |
|
Keepers Holdings Inc
PSE:KEEPR
|
Philippines | ₱2.37 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down CB Scientific Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 6.91 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CB Scientific Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CB Scientific Inc (2016–2025)
The table below shows the annual total liabilities of CB Scientific Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $2.12 Million | +125.25% |
| 2024-03-31 | $943.17K | +38.36% |
| 2023-03-31 | $681.70K | +313.56% |
| 2022-03-31 | $164.84K | -67.14% |
| 2021-03-31 | $501.72K | -75.82% |
| 2020-03-31 | $2.08 Million | +94.31% |
| 2019-03-31 | $1.07 Million | -16.19% |
| 2018-03-31 | $1.27 Million | +117.54% |
| 2017-03-31 | $585.76K | +25.75% |
| 2016-03-31 | $465.83K | -- |